Department of Cancer Biology
Thomas Jefferson University, USA
Dr. Zhongjie Shi has received his MD at Harbin Medical University (China) in 2001, and PhD at Temple University (USA) in 2011. He finished his resident training in Obstetrics and Gynecology at Sun Yat-sen University in 2005. Currently, he is working as research associate in the Department of Cancer Biology, Thomas Jefferson University. He has successfully completed his administrative responsibilities as editor-in-chief of "Medical Review". He also has been serving as an experienced reviewer of a dozen of reputed journals in the field, such as Obstetrics & Gynecology, American Journal of Obstetrics Gynecology, European J Obstetrics & Gynecology and Reproductive Biology, International J Gynecology Obstetrics, International Journal of Infectious Diseases, Pediatric Infectious Disease Journal, Archives of Virology, Vaccine, Archives of Gynecology and Obstetrics, International Journal of Women′s Health, Therapeutics and Clinical Risk Management, Research and Reports in Neonatology, and Chinese Medical Journal (English edition), with over 70 manuscripts reviewed. He has authored over 40 peer reviewed research articles and books in the field of Obstetrics and Gynecology and hepatology, which have been cited hundreds of times worldwide. His research work has been reported multiple times by Reuter Health, Faculty 1000, The Doctors Channel, Medscape, etc.
RNA-induced silencing complex (RISC)/Ribonuclease III pathway, Cancer research, HBV combinatorial therapy, Infectious disease/ STD, Fulminant hepatitis in late pregnancy, Hepatology, Laparoscopy, Meta-analysis of topics in infectious disease and medicine such as:Interruption of mother-to-child transmission of hepatitis B virus, Complications in pregnancy, Cesarean section and related issues, Infertility /In vitro fertilisation (IVF)/Embryonic development.